With box warnings

Without box warnings

Branded

Generic

2 results

tecentriq
(atezolizumab)
Genentech, Inc.
Usage: TECENTRIQ is indicated for treating various cancers, including: non-small cell lung cancer (adjuvant and metastatic), extensive-stage small cell lung cancer, unresectable or metastatic hepatocellular carcinoma, BRAF V600 mutation-positive melanoma, and unresectable or metastatic alveolar soft part sarcoma.
tecentriq hybreza
(atezolizumab and hyaluronidase-tqjs)
Genentech, Inc.
Usage: TECENTRIQ HYBREZA is indicated for treating various cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (ES-SCLC), unresectable or metastatic hepatocellular carcinoma (HCC), BRAF V600 mutation-positive melanoma, and unresectable or metastatic alveolar soft part sarcoma (ASPS) in adults.

Medications for Alveolar Soft Part Sarcoma

tecentriq